SOFTOX SOLUTIONS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.202 NOK | -1.46% |
|
-8.18% | -93.77% |
| Apr. 18 | Transcript : SoftOx Solutions AS - Special Call | |
| Mar. 20 | SoftOx Solutions AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
SoftOx Solutions AS is a Norway-based medtech and biotech company, that develops products to help fight infections from viruses, biofilm resistance and antimicrobial resistance. It is a developer of infection control solutions for disinfection, wound care and the respiratory tract. The current business segments can be divided into: Wounds, Disinfection and Respiratory. SoftOx Solutions is engaged in the development of a range of products that can be classified as either medical devices or medicinal products for human use. SoftOxâs product portfolio includes such products as SafeDes+, a hand disinfectant for irritated, compromised and eczematous skin. The Company has several subsidiaries, including SoftOx Disinfection AS, SoftOx Defense Solutions AS and SoftOx Denmark AS.
Calendar
2024-04-24
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -93.77% | 9.44M | |
| -1.61% | 105B | |
| +3.70% | 97.5B | |
| +1.86% | 22.19B | |
| -16.72% | 21.33B | |
| -8.49% | 18.68B | |
| -42.33% | 16.6B | |
| -20.34% | 14.52B | |
| +5.49% | 14.09B | |
| +28.76% | 10.99B |
- Stock Market
- Equities
- SOFTX Stock
- News SoftOx Solutions
- SoftOx Solutions Completes Early-stage Trial for Treatment of Chronic Wounds; Shares Drop 6%
